Guggenheim Raises Eli Lilly Price Target To $948, Cites Strong Mounjaro Trends
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameEli Lilly & Company
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









